G-CSF-primed haplo-identical HSCT with intensive immunosuppressive and myelosuppressive treatments does not increase the risk of pre-engraftment bloodstream infection: a multicenter case-control study.
Ren J, Lin Q, Chen W, Lin C, Zhang Y, Chen C, Chen S, Yuan X, Chen P, Luo X, Lin Y, Shen L, Guo M, Chen Q, Xiao M, Chen Y, Wu X, Zeng Y, Chen Z, Ma X, Hu J, Yang T.
Ren J, et al.
Eur J Clin Microbiol Infect Dis. 2019 May;38(5):865-876. doi: 10.1007/s10096-019-03482-6. Epub 2019 Jan 26.
Eur J Clin Microbiol Infect Dis. 2019.
PMID: 30685808
Clinical Trial.